Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.

The most common cholesterol-lowering drugs are statins, such as Lipitor and Crestor. These work by reducing the amount of ...

Keeping kids healthy can be a big job. From the day their children are born, parents ferry them to and from medical offices, getting their immune systems boosted, teeth cleaned, eyes checked and ...

Dr. Jason Schott and Dr. Geoffrey Cousins state that cardiovascular disease is the number one killer in the United States.

If you’ve been diagnosed with high cholesterol, try these high-fiber recipes, which are lower in saturated fat to help ...

Chenodiol -- a naturally occurring human bile acid also known as chenodeoxycholic acid -- is the first FDA-approved drug indicated for the rare lipid storage disease and autosomal recessive genetic ...

The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

Despite the prevalence of cardiovascular disease, many people are unclear about the role their genes play and how to lower their risk.

Mirum Pharmaceuticals' Ctexli wins FDA approval for CTX, a rare lipid storage disease. The company projects 2025 global sales of $420–$435 million.

"Our findings in this study leave no room for doubt," said University of São Paulo researcher Isabela Benseñor.

Elevated high-density lipoprotein cholesterol (HDL-C) is associated with an increased risk for glaucoma, while elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and ...